Developer docs
API playgroundTry for free, no card

Search company profiles

Krsnaa Diagnostics

Full company profile

uuid0003hnj

Namestring
Krsnaa Diagnostics
Legal namestring
Krsnaa Diagnostics Ltd
Company typeenum
Public
Founded yearint
2011
Descriptiontext

Krsnaa Diagnostics Ltd is an India-based publicly listed diagnostic services provider (BSE: 543328, NSE: KRSNAA) headquartered in Pune, Maharashtra, founded in 2011 with operations spanning 1,001-5,000 employees. The company operates a hub-and-spoke diagnostic network comprising 1,000+ centers across India offering a comprehensive menu of 1,394 radiology tests and 2,544 pathological tests through CT, MRI, X-Ray, ultrasound, and pathology services, supported by a 4,578 sq.ft. NABH-accredited tele-radiology hub in Pune with capacity for 80 technologists.

The business operates through a dual model: a public-private partnership (PPP) framework with state governments — including Himachal Pradesh, Maharashtra, Uttar Pradesh, Odisha, Delhi, Rajasthan, Tripura, Chandigarh, Karnataka, and Punjab — providing CT, MRI, and pathology services at 50-70% discounted rates under managed-services contracts; and a B2C retail vertical branded Krsnaa Retail/Krsnaa RPL operating 3,500+ touchpoints across 5 states with home collection and online booking. The company holds NABH, NABL, CAP, ACR, and CMMI Level-3 accreditations.

FY26 consolidated revenue was Rs 772.77 crore with net profit of Rs 101.43 crore (30.69% YoY growth, partly inflated by a Rs 22.20 crore one-off gain). The PPP segment carries significant counterparty risk, evidenced by the February 2026 Karnataka service halt over disputed payments of Rs 143.78 crore and reduced FY27 guidance of Rs 100-150 crore for the Rajasthan project. Upcoming expansion includes PET & LINAC oncology services. The company has served 81 million+ patients since inception.

Short descriptiontext

Krsnaa Diagnostics is an India-based publicly listed diagnostic services provider operating 1,000+ centers across India, delivering radiology and pathology services through state government PPP contracts and a B2C retail network (Krsnaa Retail) across 5 states.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
1,001–5,000
akta.pro rankint
HeadquartersPune, India
HQ citystring
Pune
HQ countrystring
India
HQ regionstring
Asia
Markets served

Serves global market

Offices3 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
diagnostic services, pathology testing, radiology imaging, tele-radiology services, public health diagnostics
Industry4 codes
PRIMARYHLACALAF
Radiology Reporting, Dictation & Structured Reporting
Healthcare & Life Sciences/Digital Health & Health IT/Medical Imaging Informatics (PACS/RIS/VNA) & Radiology IT
SECONDARYHLAHACAL
Remote Diagnostics & Home Testing Devices (Connected POC/At-Home Diagnostic Readers)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Patient Monitoring, Wearables & Remote Diagnostics
SECONDARYHLACALAL
Quality, Peer Review & Compliance Tools (MQSA/ACR/QA)
Healthcare & Life Sciences/Digital Health & Health IT/Medical Imaging Informatics (PACS/RIS/VNA) & Radiology IT
SECONDARYHLAAALAA
Molecular Diagnostics (PCR/qPCR, NGS-based assays)
NAICS code2 codes
  • Diagnostic Imaging Centers621512
  • Medical and Diagnostic Laboratories6215
SIC code1 code
  • Services-Medical Laboratories8071
Product category
Diagnostic Imaging and Pathology Services
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model3 records
1Government PPP Contracts
TypeManaged Services
Description

Revenue from public-private partnership projects with state governments and public hospitals for CT, MRI, and diagnostic services. FY26 net sales of Rs 772.77 crore with 30.69% profit growth. Rajasthan project guidance lowered to Rs 100-150 crore for FY27.

business-standard.com
2Retail Diagnostics (Krsnaa Retail)
TypeTransaction Fee
Description

B2C retail diagnostics vertical serving individual patients, achieving 8-fold revenue jump within 12 months, expanding to 3,500 locations across 5 states. Services include pathology, radiology, and home collection.

business-standard.com
3Tele-Radiology Services
TypeSubscription Recurring
Description

Remote diagnostic reporting services provided through NABH-accredited tele-radiology hub, supporting hospital and public health institution partnerships across multiple states.

financialexpress.com
Marketing channels4 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels3 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Operations, Infrastructure, Technology or R&D, Supply Chain
Pricing details1 tier
1PPP Government Pricing - 50-70% discounted rates
ModelTransaction based/ take rateBilling cadencePay-as-you-go
Notes

Services under public-private partnership framework offered at significantly discounted rates (50-70% discount) compared to standard market pricing

financialexpress.com
GTM typeB2B and B2C
B2B and B2C
Offering typeServices
Services
Brand1 of 2 records shown
1Krsnaa Retail
Description

Retail diagnostics vertical that achieved an 8-fold revenue jump within 12 months, expanding to 3,500 locations across 5 states

business-standard.com
+1 more record
Core offering1 text field

Krsnaa Diagnostics is a publicly listed Indian diagnostic services provider operating a hub-and-spoke network of 1,000+ diagnostic centres offering 1,394 radiology tests and 2,544 pathological tests. The company delivers CT, MRI, X-Ray, ultrasound, pathology, and tele-radiology/tele-pathology services primarily through public-private partnership (PPP) contracts with state governments and through its Krsnaa Retail sub-brand serving individual patients across 3,500+ retail locations in 5 states.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 4 values shown
  • 81 million+ patients served since inception
+3 more records
Product overview1 text field

Krsnaa Diagnostics operates as a comprehensive diagnostic services provider offering both radiology and pathology services through a network of diagnostic centres. The portfolio includes core imaging services (CT & X-Ray, MRI, USG), pathology testing (2,544 pathological tests and 1,394 radiology tests), tele-medicine capabilities (Tele-Radiology and Tele-Pathology), and upcoming PET & LINAC oncology services. The company operates under a hub-and-spoke model with a NABH-accredited tele-radiology hub in Pune supporting distributed diagnostic centres, complemented by the retail-focused Krsnaa Retail (KRSNAA RPL) sub-brand for direct patient access.

Product and service1 record
1Pathology Services
Scale indicator8 records

Each record includes

Type, Value, Description, Source

Partnership3 partners
1Karnataka Government (Health Department)
Strategic tierCoreTypeImplementation/ SI/ Consulting PartnerAnnounced on2023-01-01
Description

PPP project for CT and MRI services in Karnataka district hospitals. Services halted in February 2026 due to disputed pending payments of approximately Rs 143.78 crore dating back to 2019.

krsnaadiagnostics.com
2State Governments (Maharashtra, Uttar Pradesh, Odisha, Delhi, Rajasthan, Tripura, Chandigarh)
Strategic tierCoreTypeImplementation/ SI/ Consulting PartnerAnnounced on2021-01-01
Description

Multiple state government partnerships for providing diagnostic services in government hospitals. Each state has separate PPP contracts for CT, MRI, and pathology services across district hospitals and healthcare institutions.

krsnaadiagnostics.com
Strategic tierCoreTypeImplementation/ SI/ Consulting PartnerAnnounced on2011-01-01
Description

First public-private partnership project involving CT services in Himachal Pradesh, marking the company's entry into government healthcare partnerships. This established the PPP model that became central to Krsnaa's business approach.

Recent move9 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Diagnostic services arm of Apollo Hospitals, operating patient-facing diagnostic centers across India. Comparable to Krsnaa in radiology and pathology service offerings, with strong hospital network referrals.

TypeDirect peer
Description

Large pan-India diagnostic chain (backed by Manipal/Mayo Clinic) with both B2C and hospital/institutional segments. Directly comparable as a multi-modality diagnostic services competitor with similar geographic footprint.

TypeDirect peer
Description

South India-focused diagnostic chain offering comprehensive pathology and radiology services. Comparable to Krsnaa in its multi-modality diagnostic services model and PPP/hospital partnership approach.

TypeDirect peer
Description

Mumbai and Western India-focused diagnostic chain offering pathology and radiology. Comparable to Krsnaa in service mix (radiology + pathology) and B2C/institutional model.

TypeEmerging player
Description

Digital health platform offering online diagnostics booking and home sample collection across India. Comparable to Krsnaa Retail in its B2C digital booking model and direct-to-consumer home collection logistics.

TypeDirect peer
Description

Listed Indian diagnostic laboratory focused on preventive and routine pathology testing at scale via hub-and-spoke model. Comparable in its lab-services operating model and pan-India reach, though with different customer mix.

TypeEmerging player
Description

Multi-city Indian diagnostic chain combining pathology, radiology, and wellness/preventive testing. Comparable to Krsnaa in its full-service diagnostic offering, with strong presence in South and Western India.

TypeBroad incumbent
Description

European-headquartered global medical diagnostics services provider with presence in India. Comparable to Krsnaa as a large-scale diagnostic services operator, though with broader geographic and service diversification.

TypeDirect peer
Description

Listed Indian diagnostic chain operating across pathology and radiology with pan-India presence. Closely comparable to Krsnaa in service mix (pathology-led), multi-city network, and B2C + institutional customer model.

TypeDirect peer
Description

India's largest listed diagnostic chain by network and B2C brand. Directly comparable as a multi-modality (pathology + radiology) diagnostics services provider serving both individual patients and institutional clients across India.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks7 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers3 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature3 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles5 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

Subsidiaries7 records

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

Compliance6 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds3 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors3 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment1 record

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Krsnaa Diagnostics

Diagnostic Imaging and Pathology Serviceskrsnaadiagnostics.com

Krsnaa Diagnostics is an India-based publicly listed diagnostic services provider operating 1,000+ centers across India, delivering radiology and pathology services through state government PPP contracts and a B2C retail network (Krsnaa Retail) across 5 states.

What Krsnaa Diagnostics does

Krsnaa Diagnostics Ltd is an India-based publicly listed diagnostic services provider (BSE: 543328, NSE: KRSNAA) headquartered in Pune, Maharashtra, founded in 2011 with operations spanning 1,001-5,000 employees. The company operates a hub-and-spoke diagnostic network comprising 1,000+ centers across India offering a comprehensive menu of 1,394 radiology tests and 2,544 pathological tests through CT, MRI, X-Ray, ultrasound, and pathology services, supported by a 4,578 sq.ft. NABH-accredited tele-radiology hub in Pune with capacity for 80 technologists.

The business operates through a dual model: a public-private partnership (PPP) framework with state governments — including Himachal Pradesh, Maharashtra, Uttar Pradesh, Odisha, Delhi, Rajasthan, Tripura, Chandigarh, Karnataka, and Punjab — providing CT, MRI, and pathology services at 50-70% discounted rates under managed-services contracts; and a B2C retail vertical branded Krsnaa Retail/Krsnaa RPL operating 3,500+ touchpoints across 5 states with home collection and online booking. The company holds NABH, NABL, CAP, ACR, and CMMI Level-3 accreditations.

FY26 consolidated revenue was Rs 772.77 crore with net profit of Rs 101.43 crore (30.69% YoY growth, partly inflated by a Rs 22.20 crore one-off gain). The PPP segment carries significant counterparty risk, evidenced by the February 2026 Karnataka service halt over disputed payments of Rs 143.78 crore and reduced FY27 guidance of Rs 100-150 crore for the Rajasthan project. Upcoming expansion includes PET & LINAC oncology services. The company has served 81 million+ patients since inception.

Krsnaa Diagnostics firmographics

Firmographics
Name
Krsnaa Diagnostics
Legal name
Krsnaa Diagnostics Ltd
Website
https://krsnaadiagnostics.com
Company type
Public
Founded year
2011
Operating status
Operating
Headcount range
1,001–5,000 employees
Short description
Krsnaa Diagnostics is an India-based publicly listed diagnostic services provider operating 1,000+ centers across India, delivering radiology and pathology services through state government PPP contracts and a B2C retail network (Krsnaa Retail) across 5 states.
Ownership category
akta.pro rank

Krsnaa Diagnostics industry classification

Industry
Product category
Diagnostic Imaging and Pathology Services
NAICS
Diagnostic Imaging Centers (621512), Medical and Diagnostic Laboratories (6215)
SIC
Services-Medical Laboratories (8071)
akta.pro industry
PRIMARYHLACALAF
Radiology Reporting, Dictation & Structured Reporting
Healthcare & Life Sciences/Digital Health & Health IT/Medical Imaging Informatics (PACS/RIS/VNA) & Radiology IT
SECONDARYHLAHACAL
Remote Diagnostics & Home Testing Devices (Connected POC/At-Home Diagnostic Readers)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Patient Monitoring, Wearables & Remote Diagnostics
SECONDARYHLACALAL
Quality, Peer Review & Compliance Tools (MQSA/ACR/QA)
Healthcare & Life Sciences/Digital Health & Health IT/Medical Imaging Informatics (PACS/RIS/VNA) & Radiology IT
SECONDARYHLAAALAA
Molecular Diagnostics (PCR/qPCR, NGS-based assays)

Keywords

  • Diagnostic services
  • Pathology testing
  • Radiology imaging
  • Tele-radiology services
  • Public health diagnostics

Where Krsnaa Diagnostics is headquartered

Location

Headquarters

HQ city
Pune
HQ country
India
HQ region
Asia

Offices3 records

Markets served

Krsnaa Diagnostics business model

Business model
GTM type
B2B and B2C
Offering type
Services
Cost components
Personnel, Operations, Infrastructure, Technology or R&D, Supply Chain

Revenue model

  1. Government PPP Contracts: Revenue from public-private partnership projects with state governments and public hospitals for CT, MRI, and diagnostic services. FY26 net sales of Rs 772.77 crore with 30.69% profit growth. Rajasthan project guidance lowered to Rs 100-150 crore for FY27.
  2. Retail Diagnostics (Krsnaa Retail): B2C retail diagnostics vertical serving individual patients, achieving 8-fold revenue jump within 12 months, expanding to 3,500 locations across 5 states. Services include pathology, radiology, and home collection.
  3. Tele-Radiology Services: Remote diagnostic reporting services provided through NABH-accredited tele-radiology hub, supporting hospital and public health institution partnerships across multiple states.

Pricing tiers

ModelBillingPrice
Transaction based/ take ratePay-as-you-goPPP Government Pricing - 50-70% discounted rates

Go-to-market motion2 records

Distribution channels3 records

Marketing channels4 records

Krsnaa Diagnostics product offering

Product offering

Core offering

Krsnaa Diagnostics is a publicly listed Indian diagnostic services provider operating a hub-and-spoke network of 1,000+ diagnostic centres offering 1,394 radiology tests and 2,544 pathological tests. The company delivers CT, MRI, X-Ray, ultrasound, pathology, and tele-radiology/tele-pathology services primarily through public-private partnership (PPP) contracts with state governments and through its Krsnaa Retail sub-brand serving individual patients across 3,500+ retail locations in 5 states.

Product overview

Krsnaa Diagnostics operates as a comprehensive diagnostic services provider offering both radiology and pathology services through a network of diagnostic centres. The portfolio includes core imaging services (CT & X-Ray, MRI, USG), pathology testing (2,544 pathological tests and 1,394 radiology tests), tele-medicine capabilities (Tele-Radiology and Tele-Pathology), and upcoming PET & LINAC oncology services. The company operates under a hub-and-spoke model with a NABH-accredited tele-radiology hub in Pune supporting distributed diagnostic centres, complemented by the retail-focused Krsnaa Retail (KRSNAA RPL) sub-brand for direct patient access.

Differentiator

Problem solved

Functional benefit

Brands

  • Krsnaa Retail: Retail diagnostics vertical that achieved an 8-fold revenue jump within 12 months, expanding to 3,500 locations across 5 states
  • Krsnaa RPL

Products and services

  • Pathology Services

Quantifiable outcome

  • 81 million+ patients served since inception
  • +3 more outcomes

Companies that use Krsnaa Diagnostics

Customer profile

Named customers3 records

Segments3 records

Ideal customer profiles3 records

Krsnaa Diagnostics technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature3 records

Krsnaa Diagnostics partnerships and signals

Strategic signal

Partnerships

Three partnerships are on record, tiered core.

  • Karnataka Government (Health Department)coreImplementation/ SI/ Consulting Partner · 1 January 2023PPP project for CT and MRI services in Karnataka district hospitals. Services halted in February 2026 due to disputed pending payments of approximately Rs 143.78 crore dating back to 2019.
  • State Governments (Maharashtra, Uttar Pradesh, Odisha, Delhi, Rajasthan, Tripura, Chandigarh)coreImplementation/ SI/ Consulting Partner · 1 January 2021Multiple state government partnerships for providing diagnostic services in government hospitals. Each state has separate PPP contracts for CT, MRI, and pathology services across district hospitals and healthcare institutions.
  • Himachal Pradesh Government (Health Department)coreImplementation/ SI/ Consulting Partner · 1 January 2011First public-private partnership project involving CT services in Himachal Pradesh, marking the company's entry into government healthcare partnerships. This established the PPP model that became central to Krsnaa's business approach.

Scale indicators8 records

Recent moves9 records

Expansion highlights6 records

Krsnaa Diagnostics competitors and assessment

Company assessment

Direct peers

  • Apollo Diagnostics: Diagnostic services arm of Apollo Hospitals, operating patient-facing diagnostic centers across India. Comparable to Krsnaa in radiology and pathology service offerings, with strong hospital network referrals.
  • Agilus Diagnostics (formerly SRL Diagnostics): Large pan-India diagnostic chain (backed by Manipal/Mayo Clinic) with both B2C and hospital/institutional segments. Directly comparable as a multi-modality diagnostic services competitor with similar geographic footprint.
  • Vijaya Diagnostic Centre: South India-focused diagnostic chain offering comprehensive pathology and radiology services. Comparable to Krsnaa in its multi-modality diagnostic services model and PPP/hospital partnership approach.
  • Suburban Diagnostics: Mumbai and Western India-focused diagnostic chain offering pathology and radiology. Comparable to Krsnaa in service mix (radiology + pathology) and B2C/institutional model.
  • Thyrocare Technologies: Listed Indian diagnostic laboratory focused on preventive and routine pathology testing at scale via hub-and-spoke model. Comparable in its lab-services operating model and pan-India reach, though with different customer mix.
  • Metropolis Healthcare: Listed Indian diagnostic chain operating across pathology and radiology with pan-India presence. Closely comparable to Krsnaa in service mix (pathology-led), multi-city network, and B2C + institutional customer model.
  • Dr. Lal PathLabs: India's largest listed diagnostic chain by network and B2C brand. Directly comparable as a multi-modality (pathology + radiology) diagnostics services provider serving both individual patients and institutional clients across India.

Emerging players

  • Tata 1mg (1mg Technologies): Digital health platform offering online diagnostics booking and home sample collection across India. Comparable to Krsnaa Retail in its B2C digital booking model and direct-to-consumer home collection logistics.
  • Neuberg Diagnostics: Multi-city Indian diagnostic chain combining pathology, radiology, and wellness/preventive testing. Comparable to Krsnaa in its full-service diagnostic offering, with strong presence in South and Western India.

Broad incumbents

  • Synlab Group: European-headquartered global medical diagnostics services provider with presence in India. Comparable to Krsnaa as a large-scale diagnostic services operator, though with broader geographic and service diversification.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks7 records

Key highlights7 records

Customer concentration

Krsnaa Diagnostics social profiles

Digital presence

Krsnaa Diagnostics compliance and trust

Trust signal

Compliance6 records

Krsnaa Diagnostics financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Krsnaa Diagnostics leadership team

Management profile

Number of profiles

Profiles5 records

Krsnaa Diagnostics subsidiaries and ownership

Company hierarchy

Subsidiaries7 records

Krsnaa Diagnostics funding detail

Funding detail

Funding overview

Funding rounds3 records

Investors3 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Krsnaa Diagnostics M&A and investment

M&A and investment

M&A

Investments1 record

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Krsnaa Diagnostics

What does Krsnaa Diagnostics do?

Krsnaa Diagnostics is a publicly listed Indian diagnostic services provider operating a hub-and-spoke network of 1,000+ diagnostic centres offering 1,394 radiology tests and 2,544 pathological tests. The company delivers CT, MRI, X-Ray, ultrasound, pathology, and tele-radiology/tele-pathology services primarily through public-private partnership (PPP) contracts with state governments and through its Krsnaa Retail sub-brand serving individual patients across 3,500+ retail locations in 5 states.

Is Krsnaa Diagnostics a public or private company?

Krsnaa Diagnostics is a public company. It is classified as public and is currently operating.

When was Krsnaa Diagnostics founded?

Krsnaa Diagnostics was founded in 2011. It employs 1,001 to 5,000 people.

Where is Krsnaa Diagnostics based?

Krsnaa Diagnostics is headquartered in Pune, India, in the Asia region.

How does Krsnaa Diagnostics make money?

Three revenue lines are on record. Government PPP Contracts are the primary driver. The others are retail Diagnostics (Krsnaa Retail) and tele-Radiology Services.

Who are Krsnaa Diagnostics's main competitors?

Direct peers on record are Apollo Diagnostics, Agilus Diagnostics (formerly SRL Diagnostics), Vijaya Diagnostic Centre, Suburban Diagnostics, Thyrocare Technologies, Metropolis Healthcare and Dr. Lal PathLabs. Emerging players are Tata 1mg (1mg Technologies) and Neuberg Diagnostics. Synlab Group is listed as a broad incumbent.

Does Krsnaa Diagnostics have an API?

No public API is recorded for Krsnaa Diagnostics.

What industry is Krsnaa Diagnostics in?

Krsnaa Diagnostics's product category is Diagnostic Imaging and Pathology Services. Its primary akta.pro industry code is HLACALAF, Radiology Reporting, Dictation & Structured Reporting, with a secondary code of HLAHACAL, Remote Diagnostics & Home Testing Devices (Connected POC/At-Home Diagnostic Readers). Its NAICS code is 621512 and its SIC code is 8071.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
Investing.comKrsnaa Diagnostics Q2 FY27 slides: record revenue, margin pressureKrsnaa Diagnostics reported record Q2 FY27 revenue of INR 2,710 million, up 32% year-over-year, but EBITDA margins compressed to 27% from 29%. Retail pathology operations reached break-even in September 2026, with full break-even expected by late Q3 or early Q4 FY27.Investing.comEarnings call transcript: Krsnaa Diagnostics posts record Q2 2026 revenue, shares fallKrsnaa Diagnostics reported record Q2 FY27 revenue of INR 271 crore, up 32% year over year, while profit after tax rose only 3% to INR 25 crore. H1 revenue crossed INR 500 crore for the first time, but EBITDA margin fell to 27% as new projects ramped up. Management expects retail operations to reach break-even by late Q3 or early Q4 FY27.CNBCTV18Here are five pharma and healthcare stocks that will be reacting to their Q2 results today - CNBC TV18Five pharma and healthcare stocks—Granules India, Wockhardt, SPARC, Krsnaa Diagnostics, and Akums Drugs—reported their September quarter results on November 3. Granules India saw revenue growth but margin softening, while Akums Drugs reported net profit more than doubling to ₹112.8 crore. The results were reported after market hours on Monday.TradingViewNews by CNBC TV18 on TradingView, 2026-11-03Five pharma and healthcare stocks reported Q2 results on November 3, with Granules India, Wockhardt, SPARC, Krsnaa Diagnostics, and Akums Drugs all posting revenue and profit figures. Akums Drugs saw net profit more than double to ₹112.8 crore, while SPARC's losses narrowed to ₹24.96 crore. The results were reported after market hours on Monday.Digital Health NewsKrsnaa Diagnostics Collaborates with Global Radiology AI Innovator AZmedKrsnaa Diagnostics partnered with France-based AZmed to evaluate its Rayvolve AI suite for radiology operations, focusing on fracture detection and triage using X-rays. The initiative aims to assess AI-assisted image analysis for reporting workflows and operational efficiency. Krsnaa processes over five million X-rays annually across 2,000 centres.Zee BusinessKrsnaa Diagnostics announces strategic AI collaboration with AZmed; shares fallKrsnaa Diagnostics announced a strategic collaboration with AZmed to evaluate AI-assisted radiology solutions, including AZtrauma for fracture detection. The company processes over 5 million X-rays annually, and shares fell 1.18% to Rs 508.90 on NSE.ScanXKrsnaa Diagnostics signs AI collaboration deal with AZmedKrsnaa Diagnostics signed a collaboration with AZmed to evaluate AI for fracture detection, targeting efficiency gains across its 5 million annual X-rays. AZmed's Rayvolve suite holds FDA and CE clearances, and the partnership aims to unlock operating leverage through scalable AI integration.ScanXKrsnaa Diagnostics gets in-principle approval for ₹566 warrant issueKrsnaa Diagnostics received in-principle approval from BSE and NSE to issue 16,21,000 convertible warrants to its promoter group at ₹566 each. The warrants convert to ₹5 equity shares, and NSE advised strengthening internal controls to prevent intra-day trading violations. The company must rectify factual errors in the BSE letter before final listing.Business StandardKrsnaa Diagnostics board OKs sale of select diagnostic equipment for Rs 120 croreKrsnaa Diagnostics' board approved the sale of diagnostic equipment for up to Rs 120 crore to identified purchasers. The transaction is part of its asset-light strategy and will not affect lender security. The company reported a 19.35% net profit fall to Rs 16.55 crore in Q1 FY27.Medical BuyerKrsnaa Diagnostics to unlock value from assets upto Rs 120 crKrsnaa Diagnostics' board approved selling identified diagnostic equipment for up to ₹120 crore to identified purchasers. The move aims to recycle capital into core operations and improve capital efficiency, with no expected material impact on profit or business.